Get the Weekly Intelligence Brief — top committee picks every Sunday.

ARGX vs DGX

argenx SE vs Quest Diagnostics — AI-powered side-by-side comparison
ARGX
argenx SE
68
Buy
VS
DGX
Quest Diagnostics
69
Buy
MetricARGXDGX
AI Score 68 69
Price $851.51 $234.30
P/E Ratio 30.62× 24.57×
ROE 17.6% 13.8%
Revenue Growth YoY
Gross Margin 89.9% 33.1%
Debt / Equity 0.01× 0.85×
Dividend Yield 0.0% 1.4%
RSI (14) 41.5 54.8
Beta -0.022 0.557
Expected Upside +0.0%

AI Committee View

Current Innellis committee reasoning for ARGX versus DGX.
DGX leads by 1 points.

DGX scores 69/100 (Buy) versus ARGX at 68/100 (Buy).

ARGX Committee View
50% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 22.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 71.3% YoY -- genuine top-line momentum — Growth
  • EPS growing 95.7% YoY — Growth
Bear Case
  • Price-to-book of 6.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
DGX Committee View
80% agreement
5 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is bollinger bandwidth of 17.6% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Bollinger bandwidth of 17.6% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ARGX Full Analysis DGX Full Analysis